The transcript highlights the evolution and challenges of Japan's regulatory system for regenerative medicine, focusing on the experiences of J-TEC, a company specializing in autologous regenerative medical products. Initially facing hurdles due to no regulations, the introduction of the PMD Act and the categorization of regenerative medical...